Bopp, A. R., Lamenza, F. F., Upadhaya, P., Ryan, N. M., Kazmierowicz, N., Jordanides, P. P., . . . Oghumu, S. Inhibition of head and neck squamous cell carcinoma by Bruton’s tyrosine kinase inhibitor ibrutinib is associated with reduction of immunosuppressive T cells. Springer.
Chicago Style (17th ed.) CitationBopp, Anna R., et al. Inhibition of Head and Neck Squamous Cell Carcinoma by Bruton’s Tyrosine Kinase Inhibitor Ibrutinib Is Associated with Reduction of Immunosuppressive T Cells. Springer.
MLA (9th ed.) CitationBopp, Anna R., et al. Inhibition of Head and Neck Squamous Cell Carcinoma by Bruton’s Tyrosine Kinase Inhibitor Ibrutinib Is Associated with Reduction of Immunosuppressive T Cells. Springer.
Warning: These citations may not always be 100% accurate.